A. Rachel Leheny

Insider Reports History

Reporting-owner location: Hayward, CA
Latest reporting-owner signature: /s/ John Dunn, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for A. Rachel Leheny

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

CalciMedica, Inc.

Security class: Common Stock
Shares / value: 356,989
Estimated value: $192,774
Report date: 25 Jun 2026
Price: $0.5400
Ownership: By Valence Investments SPV IV, LLC

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

CalciMedica, Inc.

Security class: Common Stock
Shares / value: 317,655
Estimated value: $171,533
Report date: 25 Jun 2026
Price: $0.5400
Ownership: Direct

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

CalciMedica, Inc.

Security class: Common Stock
Shares / value: 316,109
Estimated value: $170,698
Report date: 25 Jun 2026
Price: $0.5400
Ownership: By Valence Investments SPV VI, LLC

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

CalciMedica, Inc.

Security class: Common Stock
Shares / value: 66,228
Estimated value: $35,763
Report date: 25 Jun 2026
Price: $0.5400
Ownership: By Valence Investments SPV V, LLC

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

CalciMedica, Inc.

Security class: Common Stock
Shares / value: 3,500
Estimated value: $1,890
Report date: 25 Jun 2026
Price: $0.5400
Ownership: By Scheibler-Leheny Family Living Trust

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

CalciMedica, Inc.

Security class: Common Stock
Shares / value: 1,000
Estimated value: $540
Report date: 25 Jun 2026
Price: $0.5400
Ownership: By Spouse

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

CalciMedica, Inc.

Security class: Warrant
Shares / value: 186,729
Estimated value
Report date: 19 Aug 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

CalciMedica, Inc.

Security class: Employee Stock Option (Right to Buy)
Shares / value: 77,625
Estimated value
Report date: 24 Jun 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by A. Rachel Leheny

4 CALC

CalciMedica, Inc.

Report period: 19 Aug 2026
Transactions: 2
Transaction value: $0
Accepted by SEC: 21 Aug 2026, 18:35
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 CALC

CalciMedica, Inc.

Report period: 25 Jun 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 29 Jun 2026, 08:45
Role: CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner
Next action: Open filing details

4 CALC

CalciMedica, Inc.

Report period: 05 Apr 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 07 Apr 2026, 21:50
Role: CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner
Next action: Open filing details

4 CALC

CalciMedica, Inc.

Report period: 21 Jul 2025
Transactions: 1
Transaction value: +$3,400
Accepted by SEC: 21 Jul 2025, 14:02
Role: CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner
Next action: Open filing details

4 CALC

CalciMedica, Inc.

Report period: 14 Jul 2025
Transactions: 1
Transaction value: +$6,175
Accepted by SEC: 15 Jul 2025, 21:29
Role: CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner
Next action: Open filing details

4 CALC

CalciMedica, Inc.

Report period: 24 Jun 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 26 Jun 2025, 18:26
Role: CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner
Next action: Open filing details

4 CALC

CalciMedica, Inc.

Report period: 23 Apr 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 25 Apr 2025, 16:30
Role: CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner
Next action: Open filing details

4 CALC

CalciMedica, Inc.

Report period: 01 Nov 2024
Transactions: 1
Transaction value: +$75,000
Accepted by SEC: 01 Nov 2024, 13:25
Role: CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner
Next action: Open filing details

4 CALC

CalciMedica, Inc.

Report period: 27 Aug 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 28 Aug 2024, 19:07
Role: CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner
Next action: Open filing details

4 CALC

CalciMedica, Inc.

Report period: 27 Aug 2024
Transactions: 1
Transaction value: +$4,190
Accepted by SEC: 27 Aug 2024, 19:44
Role: CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner
Next action: Open filing details

4 CALC

CalciMedica, Inc.

Report period: 28 Mar 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 22 Apr 2024, 21:33
Role: CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner
Next action: Open filing details

4 CALC

CalciMedica, Inc.

Report period: 23 Jan 2024
Transactions: 3
Transaction value: +$400,004
Accepted by SEC: 25 Jan 2024, 20:00
Role: CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner
Next action: Open filing details

4 CALC

CalciMedica, Inc.

Report period: 07 Nov 2023
Transactions: 1
Transaction value: +$6,680
Accepted by SEC: 08 Nov 2023, 20:42
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 CALC

CalciMedica, Inc.

Report period: 06 Nov 2023
Transactions: 1
Transaction value: +$7,615
Accepted by SEC: 07 Nov 2023, 18:09
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 CALC

CalciMedica, Inc.

Report period: 03 Nov 2023
Transactions: 1
Transaction value: +$14,250
Accepted by SEC: 06 Nov 2023, 18:39
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4/A CALC

CalciMedica, Inc.

Report period: 08 Jun 2023
Transactions: 1
Transaction value: +$5,225
Accepted by SEC: 15 Jun 2023, 19:51
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 CALC

CalciMedica, Inc.

Report period: 06 Jun 2023
Transactions: 2
Transaction value: +$10,376
Accepted by SEC: 08 Jun 2023, 21:09
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 CALC

CalciMedica, Inc.

Report period: 02 Jun 2023
Transactions: 1
Transaction value: +$4,800
Accepted by SEC: 05 Jun 2023, 19:25
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 CALC

CalciMedica, Inc.

Report period: 31 May 2023
Transactions: 1
Transaction value: +$4,210
Accepted by SEC: 01 Jun 2023, 19:49
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 CALC

CalciMedica, Inc.

Report period: 23 May 2023
Transactions: 1
Transaction value: +$10,032
Accepted by SEC: 24 May 2023, 20:15
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4/A CALC

CalciMedica, Inc.

Report period: 16 May 2023
Transactions: 1
Transaction value: +$2,698
Accepted by SEC: 05 Jun 2023, 19:23
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 CALC

CalciMedica, Inc.

Report period: 08 May 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 10 May 2023, 18:16
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 CALC

CalciMedica, Inc. /DE/

Report period: 20 Mar 2023
Transactions: 17
Transaction value: $0
Accepted by SEC: 22 Mar 2023, 20:47
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

3 CALC

CalciMedica, Inc. /DE/

Report period: 20 Mar 2023
Transactions: 0
Transaction value: $0
Accepted by SEC: 22 Mar 2023, 20:36
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

Insider Reports History

Continue from this owner filing history

Reported holdings for A. Rachel Leheny

Insider Reports Filed by A. Rachel Leheny